Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-27T19:59:46.324Z Has data issue: false hasContentIssue false

Update on the campylobacter epidemic from chicken meat in New Zealand: The urgent need for an upgraded regulatory response

Published online by Cambridge University Press:  15 December 2020

M. G. Baker*
Affiliation:
Department of Public Health, University of Otago, Wellington, New Zealand
L. Grout
Affiliation:
Department of Public Health, University of Otago, Wellington, New Zealand
N. Wilson
Affiliation:
Department of Public Health, University of Otago, Wellington, New Zealand
*
Author for correspondence: M. G. Baker, E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

New Zealand has a long-running campylobacter infection (campylobacteriosis) epidemic with contaminated fresh chicken meat as the major source. This is both the highest impact zoonosis and the largest food safety problem in the country. Adding to this burden is the recent rapid emergence of antibiotic resistance in these campylobacter infections acquired from locally-produced chicken. Campylobacteriosis rates halved in 2008, as compared with the previous 5 years, following the introduction of regulatory limits on allowable contamination levels in fresh chicken meat, with large health and economic benefits resulting. In the following decade, disease rates do not appear to have declined further. The cumulative impact would equate to an estimated 539 000 cases, 5480 hospitalisations, 284 deaths and economic costs of approximately US$380 million during the last 10 years (2009–2018). Additional regulatory interventions, that build on previously successful regulations in this country, are urgently needed to control the source of this epidemic.

Type
Short Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press

Text

In New Zealand, contaminated chicken meat is the largest single source of human campylobacteriosis. A huge increase in campylobacteriosis from 1980 to 2005 was closely correlated with the rise in fresh chicken meat consumption [Reference Baker1]. Rates of notifications and hospitalisations halved during 2007 after regulatory measures were introduced to reduce contamination levels in fresh chicken meat [Reference Sears2]. Key regulatory interventions introduced in 2005–2008 to reduce poultry-associated campylobacteriosis in New Zealand included monitoring and reporting the prevalence of Campylobacter spp. in caecal samples taken from birds from each growing shed each time birds were sent for processing; monitoring and reporting enumerated levels of Campylobacter spp. from rinsates of bird carcasses at the end of primary processing; mandatory targets for Campylobacter spp. contamination levels on poultry carcasses after primary processing; and intermittent monitoring of Campylobacter spp. contamination of retail poultry [Reference Sears2]. There was also a significant decline in Guillain-Barré syndrome (GBS), an uncommon but serious consequence of this infection [Reference Baker3]. However, even after a halving of notification rates after 2007, incidence remains high by global standards at 142 per 100 000 in 2018 [4]. This rate is more than seven times that of the USA (19.5 per 100 000 in 2018 [Reference Tack5]).

Figure 1 illustrates the long-term rates of notification and hospitalisations. In the 11 years following the successful intervention in 2006–2007, the notification rate declined significantly (P < 0.012) by 8.5%, whereas hospitalisations for severe disease rose significantly (P < 0.005) by 38.7%. This pattern is of concern and suggests no substantive decline in campylobacteriosis in the last decade and potentially that the epidemic is increasing based on the large rise in hospitalisation rates.

Fig. 1. Campylobacteriosis notification and hospitalisation rates (cases per 100 000 per year), based on notification data from The Institute of Environmental Science and Research Limited (ESR) and hospital discharge data (principal and additional diagnosis) from the Ministry of Health.

Many epidemiological studies in New Zealand have implicated chicken meat in this epidemic [Reference Baker6, Reference Ikram7]. A recent high-quality case-control study with source attribution found that 84% of cases were infected with strains attributed to a poultry source of campylobacteriosis [Reference Lake8].

This ongoing foodborne epidemic has major health and economic consequences for New Zealand. Contaminated fresh chicken meat is estimated to cause more than 53900 symptomatic cases of human campylobacteriosis a year in this country. This estimate is based on the average number of notified cases of 6898 per year (2009–2018); a multiplier of 9.3 for estimating the number of community cases for each notified case, which was obtained from the Infectious Intestinal Diseases Study conducted in the UK [Reference Tam9]; and source attribution of 84% from poultry [Reference Lake8].

Campylobacteriosis is frequently a serious illness. It is by far the main cause of hospitalisation for a notifiable disease in New Zealand, with an average of 652 cases hospitalised each year (2009–2018). It is reasonable to estimate that contaminated chicken is responsible for around 84% of those hospitalisations (i.e., 548 per year). Around 30 of these infections will typically cause paralysis (i.e., GBS [Reference Baker3]) and others will result in serious invasive illness and death. The experience of an outbreak in the New Zealand town of Havelock North in August 2016 provides an idea of the potential mortality impact. This waterborne outbreak resulted in 7570 cases with four deaths, suggesting a mortality risk of approximately 52 per 100 000 cases [Reference Gilpin10]. Applied to the estimate of 539 000 chicken-associated cases, this suggests 284 deaths during the last 10 years or an average of 28 per year (2.4 per month) could be attributed to this particular food source. While this estimate is only a starting point for further research, it gives an indication of the potential scale of deaths from this contaminated food.

Contaminated chicken meat also provides a highly effective vehicle for disseminating antimicrobial resistance (AMR). A tetracycline and fluoroquinolone-resistant strain of campylobacter, first detected in chicken in 2014, spread rapidly across the North Island of New Zealand. By 2015 this strain was causing about a third of human campylobacteriosis cases in the country's largest city: Auckland [Reference French11]. The larger concern is that this episode shows how vulnerable the heavily contaminated poultry flocks in this country are to the entry and dissemination of AMR organisms.

Campylobacteriosis is the costliest foodborne disease in New Zealand, with estimated annual economic costs of NZ$134 million (m) in 2006–2007 (95% CI $101 to 172 m; with the point estimate equivalent to $170 m in 2019) [Reference Lake12]. Given a halving in incidence after 2007 and assuming 84% attribution to chicken, we can assign a minimum cost of $56 m (US$38 m) per annum to this specific contaminated food source. This cost is largely paid for by consumers suffering illness, employers and the government-funded health sector rather than by the poultry industry, which is the primary source.

As an island nation which produces almost all of its own poultry, New Zealand is well placed to take immediate action to better manage this epidemic. Responsible agencies, notably the Ministry of Primary Industries (MPI) and Food Standards Australia and New Zealand (FSANZ), should assign a high priority to control the campylobacteriosis epidemic linked to contaminated fresh chicken meat based on its huge human health and economic impact. MPI should regulate to markedly lower campylobacter levels permitted on fresh poultry. This intervention has proven success in reducing human infections from this source in the New Zealand setting [Reference Sears2]. Additionally, FSANZ should regulate to require high-quality consumer information labelling of poultry. There are currently minimal requirements for food safety labelling of fresh chicken meat sold in New Zealand [Reference Allan13], which is in stark contrast to large pictorial warning labels on tobacco products. If necessary, consumers should be actively shifted to safer food sources, beginning with restricting sales to only pre-cooked and frozen chicken products [14].

New Zealand's experience with this epidemic provides several important lessons that have relevance to the control of other foodborne diseases and public health problems more generally. First, slowly evolving epidemics can get less attention than they deserve. In general, a common source foodborne outbreak affecting more than a few dozen people typically results in an investigation and strong response if a source is identified. For example, the Havelock North outbreak of campylobacteriosis from contaminated water triggered a major inquiry [15, 16]. However, the country's well-characterised ‘common source’ campylobacteriosis epidemic is not receiving a vigorous response despite causing more human cases than all of New Zealand's reported foodborne disease outbreaks combined [17].

Effective public health surveillance of diseases and hazards is essential to guide improved food safety. However, overwhelming laboratory, epidemiological and economic evidence is not always enough to drive effective regulatory responses. Despite the growing quantity of high-quality research evidence about the role of contaminated chicken meat in causing the campylobacteriosis epidemic in New Zealand, there have been minimal further interventions in over a decade (from 2007 to 2019) and rates of notified and hospitalised disease do not suggest a decline in campylobacteriosis burden in that time.

Regulating food producers is more effective than educating consumers and is highly cost-effective [Reference Duncan18]. It is difficult for chicken meat consumers to prevent infection from this highly contaminated food and cross-contamination from fresh chicken to other foods is a challenging problem and requires consistently good food handling practices by everyone involved in the food distribution chain. The scale and difficulty of this behaviour change are large compared with the proven benefits of reducing contamination levels on chicken supplied by producers [Reference Sears2].

Food safety interventions also depend on having a highly effective food safety regulator with an overriding focus on protecting public health and demonstrated independence from commercial interests. Ultimately, food safety regulation is a political process and benefits from advocacy from consumer groups and independent researchers who can provide informed critique of food safety issues. Regulators may be too cautious, under-resourced and constrained to act and may need external support to maintain momentum with enhancing food safety.

By every measure of importance, New Zealand's ongoing campylobacteriosis epidemic from contaminated chicken meat justifies a vigorous, multi-agency response. Adding up the impact of this epidemic during the last 10 years of inaction would equate to at least 539 000 cases of campylobacteriosis, 5480 hospitalisations, 284 deaths and economic costs to New Zealand of NZ$560 m (US$380 m).

The large Havelock North waterborne outbreak of campylobacter infection resulted in an exhaustive inquiry and a complete national reorganisation of the drinking-water supply sector [15, 16]. That common source outbreak caused about 7570 cases. By comparison, the ‘common source’ epidemic caused by contaminated chicken meat results in this number of campylobacteriosis cases every 2 months in New Zealand. It is probably time for a national inquiry to identify an effective response to this national epidemic from chicken meat. Responsibility for managing food safety also needs to shift to an independent regulator, potentially as part of a revitalised public health agency.

Acknowledgements

We thank Jane Zhang for data analysis and the many New Zealand researchers who have worked to provide the evidence base on which this update is based.

Disclaimer

None.

Conflict of interest

Michael Baker is partly supported by funding from the Health Research Council of New Zealand (20/631). The authors declare no other conflicts of interest.

Data availability

The authors confirm that the data supporting the findings of this study are available within the article and its references.

References

Baker, M et al. (2006) Regulation of chicken contamination is urgently needed to control New Zealand's Serious campylobacteriosis epidemic. New Zealand Medical Journal 119, U2264.Google ScholarPubMed
Sears, A et al. (2011) Marked campylobacteriosis decline after interventions aimed at poultry, New Zealand. Emerging Infectious Diseases 17, 10071015.CrossRefGoogle ScholarPubMed
Baker, MG et al. (2012) Declining Guillain-Barre syndrome after campylobacteriosis control, New Zealand, 1988–2010. Emerging Infectious Diseases 18, 226233.CrossRefGoogle ScholarPubMed
ESR: Institute of Environmental Science and Research Limited (2019) Monthly Notifiable Disease Surveillance Report – December 2018. Wellington. Available at https://surv.esr.cri.nz/PDF_surveillance/MthSurvRpt/2018/12Dec/201812_December18.pdf.Google Scholar
Tack, DM et al. (2019) Preliminary incidence and trends of infections with pathogens transmitted commonly through food – foodborne diseases active surveillance network, 10 US sites, 2015–2018. Morbidity and Mortality Weekly Report 68, 369.CrossRefGoogle Scholar
Baker, M et al. (2005) Findings and methodological lessons from a small case-control study into campylobacteriosis in Wellington. New Zealand Medical Journal 118, U1622.Google ScholarPubMed
Ikram, R et al. (1994) A case control study to determine risk factors for campylobacter infection in Christchurch in the summer of 1992–3. New Zealand Medical Journal 107, 430432.Google ScholarPubMed
Lake, RJ et al. (2020) Source attributed case-control study of campylobacteriosis in New Zealand. International Journal of Infectious Diseases 103, 268277.CrossRefGoogle ScholarPubMed
Tam, CC et al. (2012) Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 61, 6977.CrossRefGoogle ScholarPubMed
Gilpin, BJ et al. (2020) A large scale waterborne Campylobacteriosis outbreak, Havelock North, New Zealand. Journal of Infection 81, 390395.CrossRefGoogle ScholarPubMed
French, NP et al. (2019) Genomic analysis of fluoroquinolone- and tetracycline-resistant Campylobacter jejuni sequence type 6964 in humans and poultry, New Zealand, 2014–2016. Emerging Infectious Diseases 25, 22262234.CrossRefGoogle ScholarPubMed
Lake, RJ et al. (2010) Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates. Risk Analysis 30, 743752.CrossRefGoogle ScholarPubMed
Allan, PD et al. (2018) Food safety labelling of chicken to prevent campylobacteriosis: consumer expectations and current practices. BMC Public Health 18, 414.CrossRefGoogle ScholarPubMed
EFSA Panel on Biological Hazards (2011) Scientific Opinion on Campylobacter in broiler meat production: control options and performance objectives and/or targets at different stages of the food chain. EFSA Journal 9, 2105.CrossRefGoogle Scholar
Government Inquiry into Havelock North Drinking Water (2017) Report of the Havelock North Drinking Water Inquiry: Stage 1 Government Inquiry into Havelock North Drinking Water: Auckland.Google Scholar
Government Inquiry into Havelock North Drinking Water (2017) Report of the Havelock North Drinking Water Inquiry: Stage 2 Auckland.Google Scholar
ESR: Institute of Environmental Science and Research Limited (2020) Annual Summary of Outbreaks. Wellington, New Zealand: Public Health Surveillance. Update:’ [cited 2020 16 November]; Available at https://surv.esr.cri.nz/surveillance/annual_outbreak.php.Google Scholar
Duncan, GE (2014) Determining the health benefits of poultry industry compliance measures: the case of campylobacteriosis regulation in New Zealand. New Zealand Medical Journal 127, 2237.Google ScholarPubMed
Figure 0

Fig. 1. Campylobacteriosis notification and hospitalisation rates (cases per 100 000 per year), based on notification data from The Institute of Environmental Science and Research Limited (ESR) and hospital discharge data (principal and additional diagnosis) from the Ministry of Health.